Company
OKYO Pharma Ltd
NASDAQ:OKYO
OKYO Pharma Ltd. is an emerging clinical-stage ophthalmology company focused on developing differentiated therapies for corneal and anterior segment diseases. The company is committed to addressing significant unmet medical needs through innovative science, targeted therapeutic approaches, and a disciplined clinical and regulatory development strategy.
103 stories · page 2 of 6